China Pioneer Pharma Holdings Ltd
HKEX:1345

Watchlist Manager
China Pioneer Pharma Holdings Ltd Logo
China Pioneer Pharma Holdings Ltd
HKEX:1345
Watchlist
Price: 2.2 HKD -3.51%
Market Cap: 2.8B HKD

Intrinsic Value

The intrinsic value of one China Pioneer Pharma Holdings Ltd stock under the Base Case scenario is 2.04 HKD. Compared to the current market price of 2.2 HKD, China Pioneer Pharma Holdings Ltd is Overvalued by 7%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
2.04 HKD
Overvaluation 7%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
China Pioneer Pharma Holdings Ltd

What is Valuation History?
Ask AI Assistant
What other research platforms think about China Pioneer Pharma Holdings Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is China Pioneer Pharma Holdings Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for China Pioneer Pharma Holdings Ltd.

Explain Valuation
Compare China Pioneer Pharma Holdings Ltd to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about China Pioneer Pharma Holdings Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
China Pioneer Pharma Holdings Ltd

Current Assets 918.5m
Cash & Short-Term Investments 173.6m
Receivables 427.5m
Other Current Assets 317.3m
Non-Current Assets 491.6m
Long-Term Investments 172.6m
PP&E 211m
Intangibles 17.8m
Other Non-Current Assets 90.2m
Current Liabilities 195.3m
Accounts Payable 158.4m
Accrued Liabilities 6.9m
Other Current Liabilities 30m
Non-Current Liabilities 130.9m
Long-Term Debt 73m
Other Non-Current Liabilities 57.9m
Efficiency

Free Cash Flow Analysis
China Pioneer Pharma Holdings Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
China Pioneer Pharma Holdings Ltd

Revenue
1.4B CNY
Cost of Revenue
-724.6m CNY
Gross Profit
635.7m CNY
Operating Expenses
-454.9m CNY
Operating Income
180.8m CNY
Other Expenses
-76.4m CNY
Net Income
104.4m CNY
Fundamental Scores

Profitability Score
Profitability Due Diligence

China Pioneer Pharma Holdings Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Positive 3Y Average ROIC
Positive 3Y Average ROE
Healthy Gross Margin
Sustainable 3Y Average Gross Margin
51/100
Profitability
Score

China Pioneer Pharma Holdings Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

China Pioneer Pharma Holdings Ltd's solvency score is 96/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
96/100
Solvency
Score

China Pioneer Pharma Holdings Ltd's solvency score is 96/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
China Pioneer Pharma Holdings Ltd

There are no price targets for China Pioneer Pharma Holdings Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for China Pioneer Pharma Holdings Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one China Pioneer Pharma Holdings Ltd stock?

The intrinsic value of one China Pioneer Pharma Holdings Ltd stock under the Base Case scenario is 2.04 HKD.

Is China Pioneer Pharma Holdings Ltd stock undervalued or overvalued?

Compared to the current market price of 2.2 HKD, China Pioneer Pharma Holdings Ltd is Overvalued by 7%.

Back to Top